EP Patent

EP2086504A2 — Diclofenac gel

Assigned to Nuvo Research Inc · Expires 2009-08-12 · 17y expired

What this patent protects

The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.

USPTO Abstract

The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.

Drugs covered by this patent

Patent Metadata

Patent number
EP2086504A2
Jurisdiction
EP
Classification
—
Expires
2009-08-12
Drug substance claim
No
Drug product claim
No
Assignee
Nuvo Research Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.